+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Imitrex"

From
Migraine - Global Drug Forecast and Market Analysis to 2030 - Product Thumbnail Image

Migraine - Global Drug Forecast and Market Analysis to 2030

  • Report
  • November 2021
  • 131 Pages
  • Global
From
Imitrex - API Insight, 2022 - Product Thumbnail Image

Imitrex - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Imitrex- Drug Insight, 2019 - Product Thumbnail Image

Imitrex- Drug Insight, 2019

  • Report
  • January 2019
  • 35 Pages
  • Global
From
  • 5 Results (Page 1 of 1)
Loading Indicator

Imitrex (sumatriptan) is a prescription medication used to treat migraine headaches. It belongs to a class of drugs known as triptans, which are used to treat moderate to severe migraine pain. Imitrex works by narrowing blood vessels around the brain, reducing inflammation and relieving pain. It is available in tablet, nasal spray, and injection forms. Imitrex is often used in combination with other medications, such as non-steroidal anti-inflammatory drugs (NSAIDs) and anti-nausea medications. Imitrex is part of the larger analgesic market, which includes medications used to treat pain. Analgesics are used to treat a variety of conditions, including headaches, muscle pain, and arthritis. They are available in a variety of forms, including over-the-counter medications, prescription medications, and natural remedies. Some companies in the Imitrex market include GlaxoSmithKline, Teva Pharmaceuticals, and Mylan. Show Less Read more